Form 4 for NPCE NeuroPace Inc
Accepted 2022-10-20 00:00:00 ET · period of report 2022-10-18 · accession 0001209191-22-054222 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-20 | 2022-10-18 | NPCE | LACOB JOSEPH | Dir | M - OptEx | $0.03 | +192 | 384 | +100% | +$5.76 |
| D | 2022-10-20 | 2022-10-18 | NPCE | LACOB JOSEPH | Dir | M - OptEx | $0.00 | -192 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-18 | M | A | 192 | $0.03 | 384 | D | — | — | |
| 2 | Derivative | Stock Option (Rt to Buy) | 2022-10-18 | M | D | 192 | $0.00 | 0 | D | $0.03 · — to 2022-11-12 | 192 Common Stock | (F2) The share underlying the option are fully vested. |